Masimo Operating Expenses 2010-2025 | MASI

Masimo operating expenses for the twelve months ending March 31, 2025 were $2.369B, a 41.74% increase year-over-year.

  • Masimo annual operating expenses for 2024 were $2.361B, a 23.51% increase from 2023.
  • Masimo annual operating expenses for 2023 were $1.912B, a 4.7% increase from 2022.
  • Masimo annual operating expenses for 2022 were $1.826B, a 89.52% increase from 2021.

Masimo Operating Expenses 2010-2025 | MASI

  • Masimo annual operating expenses for 2024 were $2.361B, a 23.51% increase from 2023.
  • Masimo annual operating expenses for 2023 were $1.912B, a 4.7% increase from 2022.
  • Masimo annual operating expenses for 2022 were $1.826B, a 89.52% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.3B
Intuitive Surgical (ISRG)$171.4B
IDEXX Laboratories (IDXX)$52.2B
Edwards Lifesciences (EW)$45.2B
Alcon (ALC)$42.4B
IQVIA Holdings (IQV)$31.6B
DexCom (DXCM)$31.4B
Mettler-Toledo (MTD)$26.6B
STERIS (STE)$24B
Waters (WAT)$17B
SONOVA HOLDING (SONVY)$16.7B
Hologic (HOLX)$15.1B
Penumbra (PEN)$9.7B
Sysmex ADR (SSMXY)$8.8B
Globus Medical (GMED)$8.4B
Teleflex (TFX)$5.3B
Glaukos (GKOS)$5.1B
TransMedics (TMDX)$4.5B
Integer Holdings (ITGR)$3.8B
LivaNova (LIVN)$2.8B
Alphatec Holdings (ATEC)$2.3B
Veracyte (VCYT)$2.3B
PROCEPT BioRobotics (PRCT)$2.1B
Nihon Kohden (NHNKY)$2.1B
Artivion (AORT)$2.1B
Elekta AB (EKTAY)$1.9B
Paragon 28 (FNA)$1.1B
Integra LifeSciences Holdings (IART)$1.1B
OPKO Health (OPK)$1B
Pulse Biosciences (PLSE)$1B